Bringing MedTech
Innovation to Patients
TechWald Holding S.p.A. – TWH Operational Holding Company supporting high growth potential early-stage companies committed to developing Healthcare Innovation.
We have a key strategy focus on MedTech industry and Medical Technologies – medical devices, equipment, digital devices and services – which can provide benefit and value for Patients, Doctors and Healthcare Systems, and reward Shareholders with a sound and ethical profit.
Our sweet spot
SEGMENTS
• Cardiovascular
• Neurovascular
• Neuromodulation
• Metabolic Diseases
• General Surgery & Endoscopy
But eager to review projects that could fit our other criteria.
THERAPEUTIC TRENDS
• Minimally invasive
• Interventional & surgical approach
• Precision medicine
• Patient remote monitoring
STAGE
Mainly interested in project at a First in Human Stage
AVERAGE FIRST INVESTMENT
Between 1 and 5 Millions Euros. Can consider higher investment based on startup attractiveness and need.
GOVERNANCE STYLE
We usually prefer to Lead the investment. Open to co-lead or evaluate other options.
WE DO NOT INVEST IN
• Pharma
• Biotech
• Diagnostic
• Fertility
We stem from the initiative of a group of medical device executives with complementary background who started TechWald Holding S.p.A. in 2018, each of them with 10 to 25+ years of experience accumulated in various healthcare multinational companies with corporate and divisional responsibilities in sales, marketing, market access, business development, clinical development and regulatory affairs, both at European and Global scale.
Unique assets and team expertise in order to ensure that, at each development stage, most of the risks traditionally faced by Institutional Shareholders are properly and timely assessed and reduced.